The ‘costs’ of facing an employment tribunal claim: increase in compensation rates, penalties and fees
From 6 April, the statutory limits on the level of compensation that employment tribunals can award will go up. Furthermore, tribunals will have the power to impose financial penalties of up to £5,000 on employers, where it determines that the employer has breached worker’s rights and the breach has one or more aggravating factors.
In addition, we are beginning to see the consequences of tribunal fees for respondents. Recent case law suggests that the general position will be that a successful claimant will recover tribunal fees paid from their employer by way of a costs order.
So what does this mean for employers? …
Click on the link below to read the rest of the Wragge & Co briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Wragge Lawrence Graham & Co
News from The Lawyer
Briefings from Wragge Lawrence Graham & Co
Wragge Lawrence Graham & Co’s finance litigation experts bring you the latest on the cases and issues affecting the lending industry.
Eli Lilly succeeds in overturning award of DNIs regarding UK, FR, IT and ES designations of its European patent
The Court of Appeal has delivered its long-awaited judgment in the Actavis v Eli Lillydispute, ruling that Actavis is not entitled to a declaration of noninfringement (DNI) of Eli Lilly’s European patent.